Quantification of Thyroid Volume Using 3-D Ultrasound Imaging
Kollorz, E.N.K., Hahn, D.A., Linke, R., Goecke, T.W., Hornegger, J., Kuwert, T.
Published in IEEE transactions on medical imaging (01.04.2008)
Published in IEEE transactions on medical imaging (01.04.2008)
Get full text
Journal Article
925P Treatment discontinuation of immune checkpoint blockade in patients with head and neck squamous cell carcinoma experiencing complete or nearly complete remission
Klinghammer, K., Heinze, B., Ivanyi, P., Pogorzelski, M., Laban, S., Raguse, J., Ochsenreither, S., Keller, U., Keilholz, U., Hahn, D.A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
880P Paclitaxel plus cetuximab for the treatment of recurrent and/or metastatic head and neck cancer after first-line checkpoint inhibitor failure: Primary analysis from the pace ace trial
Fuereder, T., Klinghammer, K., Hahn, D.A., Grünberger, B., Melchardt, T., Greil, R., Kocher, F., Gamerith, G., Wagner, C., Berchtold, L., Burian, M., Strobl, A.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
681P OPTIM: A randomized phase II study on the OPTimization of IMmunotherapy in squamous carcinoma of the head and neck – AIO-KHT-0117
Gruenwald, V., Alt, J., Tometten, M., Haenel, M., Ivanyi, P., Schuch, G., Klinghammer, K., Gutsche, K., Hasenkamp, J., Hapke, G., Mänz, M., Weichert, W., Hahn, D.A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1784TiP Pasireotide as maintenance treatment in SSTR2/3/5-expressing synovial sarcoma and desmoplastic small round cell tumor: The PAMSARC study
Schlenk, R.F., Heining, C., Gnutzmann, E., Roldan, S.S.L., Heiligenthal, L., Sparber Sauer, M., Hahn, D.A., Dirksen, U., Hamacher, R.W., Floercken, A., Thorwarth, A., Deinzer, C., Gaidzik, V., van Tilburg, C.M., Hübschmann, D., Arndt, K., Pfister, S.M., Glimm, H., Fröhling, S., Heilig, C.E.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
873P Nivolumab (NIVO) in the first-line (1L) or second-line (2L) and later (2L+) settings in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Updated results from the German non-interventional study (NIS), HANNA
Dietz, A., Hahn, D.A., Langer, C., Kubuschok, B., Bockmühl, U., Mueller-Huesmann, H., Klautke, G., Reuter, B., Grün, J. von der, Beutner, D., Büntzel, J., Busch, C-J., Tamaskovics, B.F., Riera Knorrenschild, J., Welslau, M.K., Gauler, T.C., Waldenberger, D., Von der heyde, E.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1496P Trabectedin for patients with advanced soft tissue sarcoma: A non-interventional, prospective, multicenter study
Grünwald, V., Pink, D., Egerer, G., Schalk, E., Augustin, M., Deinzer, C.K., Kob, V., Reichert, D., Kebenko, M., Brandl, S.F., Hahn, D.A., Lindner, L.H., Hoiczyk, M., Ringsdorf, U., Hanker, L., Hempel, D., Pontes, M.J., Wismann, T., Ivanyi, P.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
927P Patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab (NIVO) in the first-line (1L) or later-line (2L+) settings in Germany: Updated results from the real-world HANNA study
Kubuschok, B., von der Heyde, E., Hahn, D.A., Langer, C., Bockmühl, U., Mueller-Huesmann, H., Klautke, G., Mauz, P-S., Reuter, B., von der Grün, J., Beutner, D., Büntzel, J., Busch, C-J., Tamaskovics, B.F., Riera Knorrenschild, J., Welslau, M.K., Gauler, T.C., Waldenberger, D., Dietz, A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
680P HANNA: Real-world data of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), including first-line population, treated with nivolumab in Germany
Langer, C., von der Heyde, E., Hahn, D.A., Kubuschok, B., Bockmühl, U., Mueller-Huesmann, H., Klautke, G., von der Grün, J., Beutner, D., Büntzel, J., Busch, C-J., Tamaskovics, B.F., Riera Knorrenschild, J., Gutsche, K., Welslau, M.K., Gauler, T.C., Waldenberger, D., Dietz, A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article